慢性心力衰竭合并肾损害患者血清白细胞介素1、白细胞介素6水平的变化及临床意义
DOI:
作者:
作者单位:

(石河子大学医学院第一附属医院心内科, 新疆石河子市 832000)

作者简介:

邹宁,硕士,研究方向为心血管疾病的临床研究,E-mail为40893930@qq.com。

通讯作者:

基金项目:


Serum levels of interleukin-1 and interleukin-6 in patients with chronic heart failure accompanied with renal damage and its clinical significance
Author:
Affiliation:

Department of Cardiology, the First Affiliated Hospital of Medical College of Shihezi University, Shihezi, Xinjiang 832000, China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨慢性心力衰竭合并肾损害患者血清白细胞介素1(IL-1)和白细胞介素6(IL-6)水平的变化及其临床意义。 方法 选取纽约心脏病学会(NYHA)心功能分级在Ⅱ~Ⅳ级的慢性心力衰竭患者220例,测定其血清尿素氮(BUN)、血肌酐(SCr)、N末端B型利钠肽原(NT-proBNP)及IL-1、IL-6水平,计算肾小球滤过率(eGFR),随机尿检测尿微量白蛋白(MAU),心脏超声测定左室射血分数(LVEF),比较不同心功能患者的IL-1、IL-6、NT-proBNP、eGFR和MAU,不同肾功能患者的IL-1、IL-6,分析IL-1、IL-6与NYHA心功能分级、NT-proBNP、LVEF、eGFR及MAU的关系。 结果 与NYHAⅡ级心功能患者相比,NYHAⅢ~Ⅳ级心功能患者血清IL-1、IL-6、NT-proBNP水平及MAU升高,eGFR降低(P<0.05),NYHAⅣ级心功能患者IL-1、IL-6、NT-proBNP水平及MAU高于NYHAⅢ级(P<0.05)。NYHAⅢ~Ⅳ级心功能患者中,30%≤EF≤50%患者血清IL-1、IL-6、NT-proBNP水平及MAU高于EF>50%患者(P<0.05),eGFR低于EF>50%患者(P<0.05),EF<30%患者IL-1、IL-6、NT-proBNP水平及MAU高于30%≤EF≤50%患者(P<0.05)。NYHAⅢ~Ⅳ级心功能患者中,肾功能不全组[eGFR<60 mL/(min·1.73 m2)]血清IL-1、IL-6水平高于肾功能正常组[eGFR≥60 mL/(min·1.73 m2)](P<0.05)。不同基础疾病的心力衰竭患者之间IL-1、IL-6水平及eGFR比较,差异无统计学意义(P>0.05)。血清IL-1、IL-6水平与NYHA心功能分级、NT-proBNP及MAU呈正相关(P<0.05),与eGFR、LVEF呈负相关(P<0.05)。 结论 慢性心力衰竭患者血清炎症因子IL-1、IL-6水平升高,与心力衰竭的严重程度和肾功能受损相关,测定血清IL-1、IL-6水平可能有助于临床心衰病情的评估。

    Abstract:

    Aim To explore the serum levels of interleukin-1 (IL-1) and interleukin-6 (IL-6) in patients with chronic heart failure accompanied with renal damage and its clinical significance. Methods 220 New York Heart Association (NYHA) functional class Ⅱ~Ⅳ patients with chronic heart failure were enrolled in this study. Serum levels of blood urea nitrogen (BUN), serum creatinine (SCr), N-terminal pro-B-type natriuretic peptide(NT-proBNP), IL-1 and IL-6 were detected, microalbuminuria (MAU) was detected randomly, left ventricular ejection fraction (LVEF) was measured by echocardiography, glomerular filtration rate (eGFR) was calculated. The levels of IL-1, IL-6, NT-proBNP, MAU and eGFR in different cardiac function groups were compared and the levels of IL-1 and IL-6 in different renal function groups were compared. The relationship between IL-1, IL-6 and NYHA functional classification, NT-proBNP, LVEF, eGFR and MAU were analysed. Results The serum levels of IL-1, IL-6, NT-proBNP and MAU in NYHAⅢ~Ⅳ groups were higher than NYHA Ⅱgroup (P<0.05), the eGFR of NYHAⅢ~Ⅳ groups were lower than NYHA Ⅱgroup (P<0.05), and the levels of IL-1, IL-6, NT-proBNP and MAU in NYHA Ⅳ group were higher than NYHA Ⅲ group (P<0.05). In NYHA functional class Ⅲ~Ⅳ patients the serum levels of IL-1, IL-6, NT-proBNP and MAU in 30%≤EF≤50% group were higher than EF>50%group (P<0.05), the eGFR of 30%≤EF≤50% group were lower than EF>50% group (P<0.05), the serum levels of IL-1, IL-6, NT-proBNP and MAU in EF<30% group were higher than 30%≤EF≤50% group (P<0.05). In NYHA functional class Ⅲ~Ⅳpatients the serum levels of IL-1, IL-6 in renal dysfunction group [eGFR<60 mL/(min.1.73m2)] were higher than normal renal function group [eGFR≥60 mL/(min.1.73m2)](P<0.05). The serum levels of IL-1, IL-6 and eGFR had no obvious difference in different basic etiologies groups (P>0.05). The serum levels of IL-1 and IL-6 were positively correlated with the NYHA functional classification, MAU and NT-proBNP (P<0.05), negatively correlated with LVEF and eGFR (P<0.05). Conclusion The serum levels of IL-1 and IL-6 are elevated in patients with chronic heart failure and correlated with the severity of chronic heart failure and renal damage, and detecting IL-1, IL-6 may provide some assistances for assessing the severity of heart failure in clinical.

    参考文献
    相似文献
    引证文献
引用本文

邹宁,庞晓,曹慧.慢性心力衰竭合并肾损害患者血清白细胞介素1、白细胞介素6水平的变化及临床意义[J].中国动脉硬化杂志,2017,25(7):710~714.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2016-11-04
  • 最后修改日期:2017-01-02
  • 录用日期:
  • 在线发布日期: 2017-07-31